Phase 3B Study Evaluating Superiority of Daily Dosing Vs Approved On/off Oral Edaravone Dosing over 48 Weeks in Patients with Amyotrophic Lateral Sclerosis (MT-1186-A02)
Journal of the Neurological Sciences（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined